CDT Conduit Pharmaceuticals
- 0.135
- -0.005-3.57%
Conduit Pharmaceuticals News
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
8-K: Current report
S-1: General form for registration of securities under the Securities Act of 1933
8-K: Current report
8-K: Current report
8-K: Current report
8-K/A: Current report (Amendment)
8-K: Current report
8-K: Current report
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
8-K: Current report
Conduit Pharmaceuticals | NT 10-K: Others
Conduit Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Conduit Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Conduit Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Conduit Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Conduit Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Conduit Pharmaceuticals | 8-K/A: Current report (Amendment)
Conduit Pharmaceuticals | 8-K: Current report
Murphy Canyon Acquisition Corp | 8-K: Current report
Analysis
Price Target
No Data
No Data